Press release
Focus day announced for SMi’s 11th annual RNA Therapeutics conference 2020
RNA Therapeutics conference 2020
SMi Group is proud to announce the return of RNA Therapeutics conference for its 11th year, commencing on 18th – 20th February 2020 in London, UK. The field of RNA therapeutics is currently undergoing major growth, and the potential for using RNA drugs for personalised medicines and immunotherapy, as well as to address genetic, infectious and chronic diseases will ensure the continued development of RNA therapeutics for years to come.
RNA Therapeutics Conference 2020 is chaired by BioNTech’s Vice President RNA Formulation and Drug Delivery, Heinrich Haas. The aim of the event is to bring together industry experts from leading RNA therapeutics companies to discuss the challenges for clinical translation of RNA-based therapeutics, with an emphasis on recent advances in delivery technologies, and present an overview of the applications of RNA-based drugs for modulation of gene and protein expression, and genome editing.
Key profiles presenting:
• Shalini Andersson, Chief Scientist New Therapeutic Modalities, AstraZeneca
• Christian Plank, CTO, Ethris
• Steve Pascolo, Founder and CEO, Miescher Pharma
• Kirsty Wydenbach, Deputy Unit Manager, Clinical Trials Unit, MhRA
• Steven Powell, CEO, eTheRNA
• Simon Newman, CSO, Nanogenics
• Christiane Niederlaender, Director, AMBR Consulting and Formerly, Quality Assessor, Biologicals, MhRA
• Klaus Giese, CEO, Pantherna Therapeutics
• David Blakey, CSO, MiNA Therapeutics
• Jeffrey Ulmer, Head Preclinical R&D, GSK
For those interested in attending, there is an early bird saving of £400 for registrations made by 31st October available at www.therapeutics-rna.com/openPR1
This year, the event has a new addition to the agenda, where a pre-conference Focus Day - ‘Oligonucleotide Delivery Systems’ is scheduled on 18th February 2020. The focus day will discuss the innovations and challenges in oligonucleotide delivery systems and will be chaired by Shalini Andersson, Chief Scientist New Therapeutic Modalities from AstraZeneca.
Featured Speakers Include:
• Enrico Mastrobattista, Professor of Pharmaceutical Biotechnology & Delivery, University Utrecht
• Pete Lutwyche, CTO, Genevant Sciences
• David Evans, CSO, Sirnaomics, Inc
• Antonin De Fougerolles, CEO, Evox Therapeutics
• Heinrich Haas, VP RNA Formulation and Drug Delivery, BioNTech
• Steve Pascolo, Founder and CEO, Miescher Pharma Gmbh
Highlights of the event:
• Discover Ethris’ mRNA therapeutic approach to pulmonary disease
• Gain insight into the opportunities and challenges in developing microRNA-based drugs from Sanofi
• Explore the progress in small activating RNAs as a novel therapeutic class of oligonucleotides from MiNA Therapeutics
• Understand how to break down the immune barrier in cancer through systemic mRNA immunisation from eTheRNA
• Learn from GSK’s discovery and development of self-amplifying mRNA vaccines
View the full agenda and speaker line-up online: www.therapeutics-rna.com/openPR1
RNA Therapeutics
Conference:19th – 20th February 2020
Focus Day: 18th February 2020
London, UK
www.therapeutics-rna.com/openPR1
Proudly sponsored by:
ChemGenes | Thermo Fisher Scientific
--- ENDS –
Contact Information:
For media enquiries contact Alia Malick on +44 (0)20 7827 6168
For all delegate enquiries, contact Hakam Panum on +44 (0)20 7827 6128
45 Curlew Street
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Focus day announced for SMi’s 11th annual RNA Therapeutics conference 2020 here
News-ID: 1842776 • Views: …
More Releases from SMI
Workable Strategic Report on Adaptive Learning Platforms Market by Forecast to 2 …
The latest research study released by Stratagem Market Insights on the "Adaptive Learning Platforms Market" with 100+ pages of analysis on business strategy taken up by emerging industry players, geographical scope, market segments, product landscape and price, and cost structure. It also assists in market segmentation according to the industry's latest and upcoming trends to the bottom-most level, topographical markets, and key advancement from both market and technology-aligned perspectives. Each…
New Technology Developments in Container Leasing Service Market to Grow during F …
The latest competent intelligence report published by SMI with the title "An Increase in Demand and Opportunities for Global Container Leasing Service Market 2023" provides a sorted image of the Container Leasing Service industry by analysis of research and information collected from various sources that have the ability to help the decision-makers in the worldwide market to play a significant role in making a gradual impact on the global economy.…
Factors Influencing Global Adaptive Digital Learning Tools Market through 2023 a …
Stratagem Market Insights has added a new research study on the Global "Adaptive Digital Learning Tools Market" 2023 by Size, Growth, Trends, and Dynamics, Forecast to 2030 which is a result of an extensive examination of the market patterns. This report covers a comprehensive investigation of the information that influences the market regarding fabricates, business providers, market players, and clients. The report provides data about the aspects which drive the…
World Leading Companies involved in The Growing Intellectual Property Protect …
The "Global Intellectual Property Protection and Management Service Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Intellectual Property Protection and Management Service industry along with various other factors over the predicted period 2023-2030. The report on the Intellectual Property Protection and Management Service market is focusing on a series of parameters including top manufacturing…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
